http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010009465-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce668b90fec413421ef59d683916e2d8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54366
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
filingDate 2009-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fb79d1aad658e782a4a4ef3a5c17cc7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac95a2d02414e9555fb21cc4592e1e34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09f8515657ab5e53a06f8c4f5f07fc43
publicationDate 2010-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2010009465-A1
titleOfInvention Method for the analysis of circulating antibodies
abstract There is provided a method for the analysis of circulating antibodies comprising the steps:n a) providing an analysis device comprising a substrate, and provided on said substrate at least one sample addition zone, at least one retaining zone, at least one sink, and at least one flow path connecting the sample addition zone, the retaining zone and the sink, wherein the flow path is open and comprises projections substantially vertical to the surface of said substrate and having a height (H), diameter (D) and reciprocal spacing (t1, t2) such that lateral capillary flow of said sample is achieved and such that cells can flow through the projections, wherein said retaining zone comprises at least one affinity binding means to which cell structures are bound, b) adding at least one sample to a sample addition zone, and c) reading a result,n nwherein circulating antibodies directed against cell structures are determined.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2281632-A1
priorityDate 2008-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5773222-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4275053-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005242017-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004063160-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002081573-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5192663-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006239859-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5759774-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007266777-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007059718-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP05088
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ38720
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID105372315

Total number of triples: 32.